Understanding Clinical Trials for Prostate Cancer | Treatment Options, Survivorship & Emerging Therapies
For many prostate cancer survivors and their families, treatment decisions can become more difficult when standard therapies stop working or no longer feel like the best fit.
In this month’s Managing Survivorship recap, Understanding Clinical Trials- A Part of Your Treatment Options, Kimberly Allman, MSN, CNP, Medical Director at Telix Pharmaceuticals, joins Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, to discuss how clinical trials may provide access to emerging treatment approaches and why they are an important part of the prostate cancer conversation.
Kimberly Allman, MSN, CNP
Medical Director
Telix Pharmaceuticals
If you were unable to attend, below are several key takeaways and highlights from the discussion:
- How clinical trials can provide patients with access to promising new prostate cancer treatments and expanded care options not otherwise available
- Some common misconceptions and concerns about patient safety
- How clinical trials evaluate new approaches to slowing or preventing cancer progression
- The importance of understanding the informed consent process and documentation
- Information on reimbursement and support available for clinical trial participation
- Guidance on using PHEN’s Find Your Trial (FYT) tool to identify relevant clinical trial opportunities
- An overview of the Merck Omaha-003, Omaha-004, and AstraZeneca EvoPAR-PR02 clinical trials
Clinical trial participation is a personal decision and may not be right for everyone, but understanding your options can help you make informed decisions about your care, future, and survivorship.
To view the meeting for the first time or replay it, please click the button below:
Thank you for being part of our growing community! If you or someone you know would benefit from our monthly managing survivorship series, register below.
We look forward to seeing you next month.
Meanwhile, here are some helpful resources for you.
Early Detection & Screening Guidelines
PHENPSA.com helps explain that prostate cancer early detection screening aims to reduce deaths from prostate cancer by detecting cancer that may be life-threatening at an early stage, where it may be treated and managed effectively.
Prostate Cancer Pathways Treatment Options
PHENPath.com helps patients to understand their treatment pathways and treatment options and supports patients in making informed and shared-decisions with their doctors.
Clinical Trials for Prostate Cancer Diagnoses
PHENTrials.com provides easy access to clinical trials for all prostate cancer diagnoses. Patients can identify and review trials that may be appropriate for them. Increasing participation saves lives.